(Q47551890)

English

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.

scientific article published on 10 September 2017

Statements

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma. (English)
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit